Metraipolis › archive › dc_3a704ad27efd

3-Hydroxymorphinan — Wikipedia (en)

Source
Wikipedia (en)
Original
https://en.wikipedia.org/wiki/3-Hydroxymorphinan
License (as archived)
CC-BY-SA-4.0
Archived
2026-11-06T12:42:58.908Z
SHA-256 of the archived text
493f78faf3b7c4d0334f9f1684c419994ed33539e18bca0dee71821191ccdf5c
Stable URL of this page
https://metraipolis.com/documento/dc_3a704ad27efd

How to cite

3-Hydroxymorphinan — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/3-Hydroxymorphinan (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_3a704ad27efd (Metraipolis archive dc_3a704ad27efd, sha256 493f78faf3b7c4d0334f9f1684c419994ed33539e18bca0dee71821191ccdf5c)
BibTeX
@misc{dc3a704ad27efd,
  title = {3-Hydroxymorphinan — Wikipedia (en)},
  howpublished = {Wikipedia (en)},
  url = {https://en.wikipedia.org/wiki/3-Hydroxymorphinan},
  note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_3a704ad27efd; sha256 493f78faf3b7c4d0334f9f1684c419994ed33539e18bca0dee71821191ccdf5c},
  year = {2026}
}

Archived text

Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/3-Hydroxymorphinan. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

3-Hydroxymorphinan (3-HM), or morphinan-3-ol, is a psychoactive drug of the morphinan family. It is the racemic counterpart to norlevorphanol. The dextrorotatory stereoisomer of the compound is an active metabolite of dextromethorphan, dextrorphan, and 3-methoxymorphinan, and similarly to them has potent neuroprotective and neurotrophic effects on LTS- and MPTP-treated dopaminergic neurons of the nigrostriatal pathway, but notably without producing any neuropsychotoxic side effects (e.g., dissociation or hallucinations) or having any anticonvulsant actions. It does not seem to bind to the NMDA receptor, and instead, its neuroprotective properties appear result from inhibition of glutamate release via the suppression of presynaptic voltage-dependent Ca2+ entry and protein kinase C activity. In any case, as such, the compound has been investigated as a potential management of Parkinson's disease medication (antiparkinsonian agent). A prodrug, GCC1290K, has been developed on account of 3-HM's poor bioavailability (18%), and a New Drug Application has been approved for it by the United States Food and Drug Administration. It is currently undergoing clinical trials for the treatment of Parkinson's disease. It does not have a Controlled Substances Act 1970 schedule, ACSCN, or annual aggregate manufacturing quota and may not necessarily be controlled, whilst norlevorphanol is; none of the dextrorotary derivatives of the dromoran and norlevorphanol sub-families of morphinan derivatives are controlled as they do not have opioid activity but the other racemic compounds are. 3-HM's levorotatory stereoisomer, norlevorphanol, in contrast to (+)-3-HM, is an opioid analgesic. It was never marketed as such however, probably due to a combination of the facts that norlevorphanol has low bioavailability and that its potency is diminished compared to its N-methylated analogue levorphanol.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico).
Fonte: Wikipedia in inglese, voce «3-Hydroxymorphinan» — https://en.wikipedia.org/wiki/3-Hydroxymorphinan
Wikidata Q4634148: «racemate» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q4634148
Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/3-Hydroxymorphinan?action=history).
Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza.
Estratto dell'introduzione non modificato nel contenuto; revisione 1329170178, consultata il 2026-11-06T12:40:22.997Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 924fd80d1f4c53a9d5eae522feccf3bfcf1fd035d9feb17a52403a3b1ba6f085